HuGE Literature Finder
Records 1-23
|
Signal peptide missense variant in cancer-brake gene CTLA4 and breast cancer outcomes.
Gene 2020 Feb 737 144435. Babteen Nouf Abubakr, Fawzy Manal S, Alelwani Walla, Alharbi Raed A, Alruwetei Abdulmohsen M, Toraih Eman A, Elshazli Rami |
|
CTLA-4 polymorphism rs231775: Influence on relapse and survival after allogeneic hematopoietic stem cell transplantation in childhood.
European journal of haematology 2019 Mar 102 (3): 251-255. Hammrich Judith, Wittig Susan, Ernst Thomas, Gruhn Ber |
|
Distinct Relapse Rates and Risk Predictors After Discontinuing Tenofovir and Entecavir Therapy.
The Journal of infectious diseases 2018 03 217 (8): 1193-1201. Su Tung-Hung, Yang Hung-Chih, Tseng Tai-Chung, Liou Jyh-Ming, Liu Chen-Hua, Chen Chi-Ling, Chen Pei-Jer, Chen Ding-Shinn, Liu Chun-Jen, Kao Jia-Hor |
|
The Influence of Genetic Variations in the CD86 Gene on the Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.
Journal of immunology research 2018 2018 3826989. Karabon Lidia, Markiewicz Miroslaw, Chrobot Karolina, Dzierzak-Mietla Monika, Pawlak-Adamska Edyta, Partyka Anna, Koclega Anna, Kyrcz-Krzemien Slawomira, Frydecka Ire |
|
The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors for Relapse in Patients with Graves Disease.
Acta medica Indonesiana 2017 Jul 49 (3): 195-204. Eliana Fatimah, Suwondo Pradana, Asmarinah Asmarinah, Harahap Alida, Djauzi Samsuridjal, Prihartono Joedo, Pemayun Tjokorda Gde Dal |
|
CTLA-4 gene polymorphisms associate with efficacy of postoperative radioiodine-131 for differentiated thyroid carcinoma.
Future oncology (London, England) 2017 Mar . Chang De-Feng, Chen Xiao-Hong, Huang Jing, Sun Ya-Mei, Zhu Da-Yong, Xu Zhong-Qi |
|
Variations in genes involved in immune response checkpoints and association with outcomes in patients with resected colorectal liver metastases.
The pharmacogenomics journal 2015 Mar . Stremitzer S, Sunakawa Y, Zhang W, Yang D, Ning Y, Stintzing S, Sebio A, Yamauchi S, Matsusaka S, El-Khoueiry R, Stift J, Wrba F, Gruenberger T, Lenz H |
|
Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations.
Nature medicine 2014 Dec 20 (12): 1410-6. Schubert Desirée, Bode Claudia, Kenefeck Rupert, Hou Tie Zheng, Wing James B, Kennedy Alan, Bulashevska Alla, Petersen Britt-Sabina, Schäffer Alejandro A, Grüning Björn A, Unger Susanne, Frede Natalie, Baumann Ulrich, Witte Torsten, Schmidt Reinhold E, Dueckers Gregor, Niehues Tim, Seneviratne Suranjith, Kanariou Maria, Speckmann Carsten, Ehl Stephan, Rensing-Ehl Anne, Warnatz Klaus, Rakhmanov Mirzokhid, Thimme Robert, Hasselblatt Peter, Emmerich Florian, Cathomen Toni, Backofen Rolf, Fisch Paul, Seidl Maximilian, May Annette, Schmitt-Graeff Annette, Ikemizu Shinji, Salzer Ulrich, Franke Andre, Sakaguchi Shimon, Walker Lucy S K, Sansom David M, Grimbacher Bo |
|
Genetic polymorphisms and risk of recurrent wheezing in pediatric age.
BMC pulmonary medicine 2014 14 162. Esposito Susanna, Ierardi Valentina, Daleno Cristina, Scala Alessia, Terranova Leonardo, Tagliabue Claudia, Rios Walter Peves, Pelucchi Claudio, Principi Nico |
|
Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012 Jul 18 (7): 1069-75. Jagasia Madan, Clark William B, Brown-Gentry Kristin D, Crawford Dana C, Fan Kang-Hsien, Chen Heidi, Kassim Adetola, Greer John P, Engelhardt Brian G, Savani Bipin |
|
Cytotoxic T-lymphocyte antigen 4 haplotype correlates with relapse and survival after allogeneic hematopoietic SCT.
Bone marrow transplantation 2011 Nov 46 (11): 1444-9. Murase M, Nishida T, Onizuka M, Inamoto Y, Sugimoto K, Imahashi N, Murata M, Miyamura K, Kodera Y, Inoko H, Naoe |
|
Do genetic polymorphisms predict risk of recurrence in patients with localized renal cell carcinoma? Results from a cohort study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 May 29 (15_suppl): 4506. Schutz F A B, Gray K P, Pomerantz M, Atkins M B, Rosenberg J E, Hirsch M S, McDermott D F, Lee G M, Signoretti S, Kantoff P W, Freedman M L, Choueiri T |
|
CTLA-4 +49A>G polymorphism of recipients of HLA-matched sibling allogeneic stem cell transplantation is associated with survival and relapse incidence.
Annals of hematology 2010 Jun 89 (6): 613-8. Piccioli Patrizia, Balbi Giuseppe, Serra Martina, Morabito Anna, Lamparelli Teresa, Gobbi Marco, Laurent Stefania, Dozin Beatrice, Bruzzi Paolo, Ferraris Anna Maria, Bacigalupo Andrea, Notaro Rosario, Pistillo Maria P |
|
Long-term follow-up of autoimmune pancreatitis: characteristics of chronic disease and recurrence.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009 Nov 7 (11 Suppl): S18-22. Kawa Shigeyuki, Hamano Hideaki, Ozaki Yayoi, Ito Tetsuya, Kodama Ryou, Chou Yoshimi, Takayama Mari, Arakura Norika |
|
Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation.
Clinica chimica acta; international journal of clinical chemistry 2009 May 403 (1-2): 229-33. Wu Jui, Tang Jih-Luh, Wu Shang-Ju, Lio Hoi-Yan, Yang Ya-Chi |
|
Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach.
Clinica chimica acta; international journal of clinical chemistry 2009 Apr 402 (1-2): 189-92. Zee Robert Y L, Bubes Vadim, Shrivastava Sanjay, Ridker Paul M, Glynn Robert |
|
CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy.
Leukemia 2009 Mar 23 (3): 486-91. Pérez-García A, Brunet S, Berlanga J J, Tormo M, Nomdedeu J, Guardia R, Ribera J M, Heras I, Llorente A, Hoyos M, Esteve J, Besalduch J, Bueno J, Sierra J, Gallardo D, |
|
Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients.
The American journal of gastroenterology 2008 Mar 103 (3): 588-94. Umemura Takeji, Ota Masao, Hamano Hideaki, Katsuyama Yoshihiko, Muraki Takashi, Arakura Norikazu, Kawa Shigeyuki, Kiyosawa Ken |
|
Susceptible alleles of the CD40 and CTLA-4 genes are not associated with the relapse after antithyroid withdrawal in Graves' disease.
Thyroid : official journal of the American Thyroid Association 2007 Dec 17 (12): 1229-34. Kim Kyung Won, Park Young Joo, Kim Tae Yong, Park Do Joon, Park Kyong Soo, Cho Bo Yo |
|
Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients.
Liver international : official journal of the International Association for the Study of the Liver 2007 Nov 27 (9): 1202-8. Jiang Zhijun, Feng Xiaoning, Zhang Wu, Gao Feng, Ling Qi, Zhou Lin, Xie Haiyang, Chen Qixing, Zheng Shus |
|
Cytotoxic T lymphocyte-associated molecule-4 gene polymorphism and hyperthyroid Graves' disease relapse after antithyroid drug withdrawal: a follow-up study.
The Journal of clinical endocrinology and metabolism 2007 Jul 92 (7): 2513-8. Wang Pei-Wen, Chen I-Ya, Liu Rue-Tsuan, Hsieh Ching-Jung, Hsi Edward, Juo Suh-Hang Ha |
|
The predictive value of CTLA-4 and Tg polymorphisms in the recurrence of Graves' disease after antithyroid withdrawal.
Endocrine 2006 Dec 30 (3): 377-81. Tanrikulu Sevda, Erbil Ye?im, Ademoglu Evin, I?sever Halim, Barbaros Umut, Kutlutürk Faruk, Ozarmagan Selçuk, Tezelman Serd |
|
Cytotoxic T lymphocyte-associated molecule-4 polymorphism and relapse of Graves' hyperthyroidism after antithyroid withdrawal.
The Journal of clinical endocrinology and metabolism 2004 Jan 89 (1): 169-73. Wang Pei-Wen, Liu Rue-Tsuan, Juo Suh-Hang Hank, Wang Shan-Tair, Hu Ya-Hui, Hsieh Ching-Jung, Chen Ming-Hong, Chen I-Ya, Wu Chia-Li |
- Page last reviewed:Mar 16, 2019
- Page last updated:Sep 18, 2020
- Content source: